Alternatives to Jazz Pharmaceuticals

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

A commercial-stage immunotherapy company focused on the development of novel treatments for B-cell malignancies and autoimmune diseases.

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Engineering scalable gene therapies for broader patient populations.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

A global leader in clinical pharmacology and bioanalytical sciences.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.